Skip to main content

Table 9 Dose response—antibodies (log10 mIU/mL)—by time interval

From: Validation of a yellow fever vaccine model using data from primary vaccination in children and adults, re-vaccination and dose-response in adults and studies with immunocompromised individuals

Dose-IU Number of individuals Average time (days) GMT day 0 GMT PV 30–45 days
31 92 27 (21–34) 2.12 2.99
158 88 27 (20–34) 2.14 3.68
587 92 28 (21–34) 2.16 4.02
3013 100 28 (21–34) 2.14 3.98
10,447 91 28 (21–34) 2.19 4.10
27,476 98 27 (21–34) 2.23 4.09